Spinal Cord Stimulator Implant Infection Rates and Risk Factors: A Multicenter Retrospective Study

Bryan C. Hoelzer*, Mark A. Bendel, Timothy R. Deer, Jason S. Eldrige, David R. Walega, Zhen Wang, Shrif Costandi, Gerges Azer, Wenchun Qu, Steven M. Falowski, Stephanie A. Neuman, Susan M. Moeschler, Catherine Wassef, Christopher Kim, Tariq Niazi, Taher Saifullah, Brian Yee, Chong Kim, Christine L. Oryhan, Joshua M. RosenowDaniel T. Warren, Imanuel Lerman, Ruben Mora, Salim M. Hayek, Michael Hanes, Thomas Simopoulos, Sanjiv Sharma, Chris Gilligan, Warren Grace, Timothy Ade, Nagy A. Mekhail, John P. Hunter, Daniel Choi, Deborah Y. Choi

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

87 Scopus citations


Objectives: Spinal cord stimulation is an evidence-based treatment for a number of chronic pain conditions. While this therapy offers improvement in pain and function it is not without potential complications. These complications include device failure, migration, loss of therapeutic paresthesia, and infection. This article looked to establish a modern infection rate for spinal cord stimulators, assess the impact of known risk factors for surgical site infections and to determine the impact of certain preventative measures on the rate of infection. Methods: After institutional review board approval, a multisite, retrospective review was conducted on 2737 unique implants or revisions of SCS systems. Patient demographics, risk factors including diabetes, tobacco use, obesity, revision surgery, trial length, implant location, implant type, surgeon background, prophylactic antibiotic use, utilization of a occlusive dressing, and post-operative antibiotic use were recorded and analyzed. Results: The overall infection rate was 2.45% (n = 67). Diabetes, tobacco use, and obesity did not independently increase the rate of infection. Revision surgeries had a trend toward higher infection rate; however, this did not meet statistical significance. There was no difference in the rate of infection between implants performed by physicians of different base specialties, cylinder leads vs. paddle leads, or between different prophylactic antibiotics. Implants performed at academic centers had a higher rate of infection when compared to implants performed in nonacademic settings. When patients received an occlusive dressing or post-operative antibiotics they had a lower rate of infection. Conclusions: The infection rate (2.45%) reported in this study is lower than the previously reported rates (3–6%) and are on par with other surgical specialties. This study did not show an increased rate of infection for patients that used tobacco, had diabetes or were obese. It's possible that given the low overall infection rate a larger study is needed to establish the true impact of these factors on infection. In addition, this study did not address the impact of poorly controlled diabetes mellitus (elevated hemoglobin A1c) vs. well-controlled diabetes. It can be concluded from this study that utilizing an occlusive dressing over the incision in the post-operative period decreases the rate of infection and should become the standard of care. This study also demonstrated the positive impact of post-operative antibiotics in decreasing the rate of infection. Studies in other surgical specialties have not shown this impact which would suggest that further research is needed.

Original languageEnglish (US)
Pages (from-to)558-562
Number of pages5
Issue number6
StatePublished - 2017


  • Antibiotic
  • complications
  • infection
  • spinal cord stimulation

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Anesthesiology and Pain Medicine


Dive into the research topics of 'Spinal Cord Stimulator Implant Infection Rates and Risk Factors: A Multicenter Retrospective Study'. Together they form a unique fingerprint.

Cite this